bez235
Showing 1 - 16 of 16
Advanced Solid Tumor Trial in Kobe-city, Yufu (BEZ235)
Completed
- Advanced Solid Tumor
- BEZ235
-
Kobe-city, Hyogo, Japan
- +1 more
Dec 6, 2020
Inoperable Locally Advanced Breast Cancer, Metastatic Breast Cancer (MBC) Trial in Dijon Cedex, Saint-Herblain Cédex, Hospitalet
Terminated
- Inoperable Locally Advanced Breast Cancer
- Metastatic Breast Cancer (MBC)
- BEZ235
- Paclitaxel
-
Dijon Cedex, France
- +2 more
Dec 6, 2020
Castration-resistant Prostate Cancer Trial in Worldwide (BEZ235, BKM120)
Completed
- Castration-resistant Prostate Cancer
- BEZ235
- BKM120
-
Los Angeles, California
- +9 more
Dec 6, 2020
Breast Cancer, Advanced Solid Tumors, Cowden Syndrome Trial in Worldwide (BEZ235)
Completed
- Breast Cancer
- +2 more
- BEZ235
-
Los Angeles, California
- +14 more
Dec 6, 2020
Carcinoma Transitional Cell Trial in Belgium, Luxembourg (BEZ235)
Terminated
- Carcinoma Transitional Cell
- BEZ235
-
Ottignies, Brabant Wallon, Belgium
- +11 more
Apr 8, 2019
Respiratory Tract Infections Trial in Wichita (Placebo, BEZ235, BEZ235 plus everolimus (RAD001))
Active, not recruiting
- Respiratory Tract Infections
- Placebo
- +2 more
-
Wichita, KansasHeartland Research Associates
May 11, 2018
Castrate-resistant Prostate Cancer Trial in San Francisco (BEZ235, Prednisone, Abiraterone acetate)
Terminated
- Castrate-resistant Prostate Cancer
- BEZ235
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 27, 2018
Acute Lymphoblastic Leukemia, Leukemia, Myelocytic, Acute, Chronic Myelogenous Leukemia With Crisis of Blast Cells Trial in
Unknown status
- Acute Lymphoblastic Leukemia
- +2 more
- BEZ235
-
Frankfurt, Hessen, GermanyJohann Wolfgang Goethe University Hospitals
Aug 16, 2017
Metastatic Breast Cancer Trial in United States (BEZ235, BKM 120, Letrozole)
Completed
- Metastatic Breast Cancer
- BEZ235
- +3 more
-
Birmingham, Alabama
- +5 more
Jul 22, 2016
Renal Cancer Trial in New York (BEZ235)
Terminated
- Renal Cancer
- BEZ235
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 1, 2016
Pancreatic Neuroendocrine Tumors (pNET) Trial in Worldwide (BEZ235, Everolimus)
Terminated
- Pancreatic Neuroendocrine Tumors (pNET)
- BEZ235
- Everolimus
-
Los Angeles, California
- +25 more
Mar 9, 2016
Malignant Solid Tumour Trial in Oklahoma City, Nashville (BEZ235)
Completed
- Malignant Solid Tumour
- BEZ235
-
Oklahoma City, Oklahoma
- +1 more
Apr 30, 2015
Malignant PEComa (Perivascular Epithelioid Cell Tumors) Trial in Barcelona (BEZ235)
Withdrawn
- Malignant PEComa (Perivascular Epithelioid Cell Tumors)
- BEZ235
-
Barcelona, Cataluña, SpainNovartis Investigative Site
Aug 1, 2013
Metastatic Breast Cancer Trial (BEZ235)
Withdrawn
- Metastatic Breast Cancer
- BEZ235
- (no location specified)
Jun 5, 2012
Endometrial Cancer Trial in Worldwide (BEZ235)
Withdrawn
- Endometrial Cancer
- BEZ235
-
Phoenix, Arizona
- +58 more
Jun 20, 2012